Eμ/miR-125b transgenic mice develop lethal B-cell malignancies

Leukemia

Volumn 25, Issue 12, 2011, Pages 1849-1856

  Enomoto, Y ^a   Kitaura, J ^a   Hatakeyama, K ^b   Watanuki, J ^c   Akasaka, T ^d   Kato, N ^a   Shimanuki, M ^c   Nishimura, K ^a   Takahashi, M ^a   Taniwaki, M ^e   Haferlach, C ^f   Siebert, R ^g   Dyer, M J S ^d   Asou, N ^h   Aburatani, H ⁱ   Nakakuma, H ^c   Kitamura, T ^a   Sonoki, T ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^g UNIVERSITY OF KIEL   (Germany)

^h KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

Author keywords

B cell malignancies; microRNA; mir 125; transgenic mouse

Indexed keywords

BCR ABL PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; MICRORNA; MICRORNA 125B; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION 11; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LETHALITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TRP53INP1 GENE;

EID: 83555166166     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.166     Document Type: Article

References (33)

1. Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000; 96: 808-822. (Pubitemid 30618048)
2. Küppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001; 20: 5580-5594. (Pubitemid 32928099)
3. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355. (Pubitemid 39265675)
4. Bartel D. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
5. Medina PP, Slack FJ. microRNAs and cancer: an overview. Cell Cycle 2008; 7: 2485-2492.
6. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-5856.
7. Sonoki T, Iwanaga E, Mitsuya H, Asou N. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia 2005; 19: 2009-2010. (Pubitemid 41554016)
8. Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008; 205: 2499-2506.
9. Chapiro E, Russell L, Struski S, Cavé H, Radford-Weiss I, Valle V et al. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia 2010; 24: 1362-1364.
10. Tassano E, Acquila M, Tavella E, Micalizzi C, Panarello C, Morerio C. MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 2010; 49: 682-687.
11. Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 2010; 24: 89-96.
12. Klusmann J, Li Z, Böhmer K, Maroz A, Koch M, Emmrich S et al. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 2010; 24: 478-490.
13. O'Connell R, Chaudhuri A, Rao D, GibsonW, Balazs A, Baltimore D. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci USA 2010; 107: 14235-14240.
14. Bousquet M, Harris MH, Zhou B, Lodish HF. MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA 2010; 107: 21558-21563.
15. Ooi AG, Sahoo D, Adorno M, Wang Y, Weissman IL, Park CY. MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc Natl Acad Sci USA 2010; 107: 21505-21510.
16. Tomasini R, Samir A, Carrier A, Isnardon D, Cecchinelli B, Soddu S et al. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem 2003; 278: 37722-37729. (Pubitemid 37175297)
17. Tomasini R, Samir A, Vaccaro M, Pebusque M, Dagorn J, Iovanna J et al. Molecular and functional characterization of the stressinduced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death. J Biol Chem 2001; 276: 44185-44192.
18. Tomasini R, Samir A, Pebusque M, Calvo E, Totaro S, Dagorn J et al. P53-dependent expression of the stress-induced protein (SIP). Eur J Cell Biol 2002; 81: 294-301. (Pubitemid 34568210)
19. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell 2001; 8: 85-94. (Pubitemid 32772907)
20. Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007; 109: 3451-3461. (Pubitemid 46572535)
21. Kato N, Kitaura J, Doki N, Komeno Y, Watanabe-Okochi N, Togami K et al. Two types of C/EBPa mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models. Blood 2011; 117: 221-233.
22. Watanabe-Okochi N, Oki T, Komeno Y, Kato N, Yuji K, Ono R et al. Possible involvement of RasGRP4 in leukemogenesis. Int J Hematol 2009; 89: 470-481.
23. Enomoto Y, Yamanishi Y, Izawa K, Kaitani A, Takahashi M, Maehara A et al. Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5. J Biol Chem 2010; 285: 35274-35283.
24. Izawa K, Kitaura J, Yamanishi Y, Matsuoka T, Oki T, Shibata F et al. Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J Biol Chem 2007; 282: 17997-18008. (Pubitemid 47100247)
25. Izawa K, Kitaura J, Yamanishi Y, Matsuoka T, Kaitani A, Sugiuchi M et al. An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. J Immunol 2009; 183: 925-936.
26. Yamanishi Y, Kitaura J, Izawa K, Matsuoka T, Oki T, Lu Y et al. Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood 2008; 111: 688-698.
27. Ono R, Nakajima H, Ozaki K, Kumagai H, Kawashima T, Taki T et al. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. J Clin Invest 2005; 115: 919-929. (Pubitemid 40489396)
28. Komeno Y, Kitaura J, Watanabe-Okochi N, Kato N, Oki T, Nakahara F et al. AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model. Leukemia 2010; 24: 1018-1024.
29. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. Pre-B cell proliferation and lymphoblastic leukemia/highgrade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006; 103: 7024-7029.
30. Gironella M, Seux M, Xie M, Cano C, Tomasini R, Gommeaux J et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 2007; 104: 16170-16175. (Pubitemid 350099380)
31. Gommeaux J, Cano C, Garcia S, Gironella M, Pietri S, Culcasi M et al. Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol 2007; 27: 2215-2228. (Pubitemid 46418477)
32. Guo S, Lu J, Schlanger R, Zhang H, Wang JY, Fox MC et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci USA 2010; 107: 14229-14234.
33. Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86-90.